For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
Scope of the Report:
This report focuses on the Transdermal Patch in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The technical barriers of transdermal patch are high, and the core technology of transdermal patch concentrates in relative large companies. These companies mainly concentrate in USA, Japan and Germany. Japan account for almost 50% of total transdermal patch in 2015, followed by North America with 29% of production share.
In the past few years, the price of transdermal patch has a little change and we expect the price will slightly lower. However, the improvement of energy, transportation costs, employee wages, and equipment depreciation will play a significant role in promoting the cost of transdermal patch.
As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. With the snatch for market share in emerging regions, the competition in transdermal patch industry will become more intense.
The worldwide market for Transdermal Patch is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Teikoku Pharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Oxybutynin Transdermal Patch
Market Segment by Applications, can be divided into
- Used to Stop Smoking Cigarettes
- Used to Treat High Blood Pressure
- Used to Relieve Severe Pain
- Used to Treat an Overactive Bladder
There are 15 Chapters to deeply display the global Transdermal Patch market.
Chapter 1, to describe Transdermal Patch Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Transdermal Patch, with sales, revenue, and price of Transdermal Patch, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Transdermal Patch, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Transdermal Patch market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Transdermal Patch sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source